pharma · Advanced Or Metastatic Merkel Cell Carcinoma · Cutaneous Melanoma, Stage III · HURA
TuHURA Biosciences, Inc./NV
TuHURA Biosciences, Inc./NV drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Tampa, USA HQ
1996 Founded
32 Employees
Public company Type
HURA · NYSE Ticker
Company details
- Status
- Public
- HQ
- Tampa, USA
- Founded
- 1996
- Employees
- 32
- Programs
- 4
- Drugs
- 0
- Patents
- 0
TuHURA Biosciences, Inc./NV pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
TuHURA Biosciences, Inc./NV drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.